- World rank, all time
- #34,997 of 42,892
- Rank in China
- #3,198 of 3,536
- Research works
- 210 ◆ 0% vs 2013–17
- Citations
- 4.2k 20.1 per fractional work
- Top-10% rate
- 17.2% record average 16.5%
- Open access
- 28% world 28%
What does Qidong Liver Cancer Prevention Research specialise in?
Where its research is concentrated relative to its size: Medicine takes 3.4× the share of its output that it takes of world research.
- MedicineField · 23.8 works3.4×
- Health SciencesDomain · 25.0 works3.0×
Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Medicine, 3.4×. Every wedge is a field page.
- Medicine 3.4×
- Neuroscience 2.6×
- Nursing 2.4×
- Biochemistry, Genetics and Molecular Biology 2.0×
- Pharmacology, Toxicology and Pharmaceutics 1.7×
- Immunology and Microbiology 1.5×
- Health Professions 0.8×
- Economics, Econometrics and Finance 0.6×
- Environmental Science 0.5×
- Materials Science 0.4×
- Chemistry 0.4×
- Psychology 0.3×
- Earth and Planetary Sciences 0.3×
- Arts and Humanities 0.2×
- Physics and Astronomy 0.2×
- Computer Science 0.2×
- Engineering 0.2×
- Agricultural and Biological Sciences 0.1×
- Social Sciences 0.1×
Who are the top researchers at Qidong Liver Cancer Prevention Research?
Ranked on the composite score, Jianguo Chen lead among researchers whose main affiliation is Qidong Liver Cancer Prevention Research.
- 1 Jianguo Chen China · #771,201 worldwide 48 citations · 29 works
Which keywords describe research at Qidong Liver Cancer Prevention Research?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Chemotherapy, Cancer, Metabolic Syndrome, Survival, Tumor Microenvironment, Oxidative Stress, Endoscopic Resection and Clinical Practice Guidelines.
- Pancreatic Cancer
- Human Papillomavirus
- Esophageal Carcinoma
- Quantitative Analysis
- NAFLD
- Pregnancy
- Biomarkers
- Medical Imaging
- Gastric Cancer
- Hepatic Steatosis
- Molecular Characterization
- Precision Medicine
- Gene Expression
- Breast Cancer
- Neoadjuvant Therapy
- Clinical Practice Guidelines
- Inflammation
- Survival
- Epidemiology
- Cancer
- Chemotherapy
- Metabolic Syndrome
- Oxidative Stress
- Tumor Microenvironment
- Endoscopic Resection
- Hepatocellular Carcinoma
- Immunotherapy
- Obesity
- Cell Death
- Insulin Resistance
- Ferroptosis
- Lipid Peroxidation
- Lymph Node Dissection
- Radiotherapy
- Body Mass Index
- Prognosis
- NASH
- Radiomics
- Gemcitabine
- Oropharyngeal Cancer
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Chemotherapy6▲ 22×9 topics
- Cancer4▲ 9.0×21 topics
- Metabolic Syndrome4▲ 12×7 topics
- Epidemiology3▲ 2.1×13 topics
- Oxidative Stress3▲ 5.1×13 topics
- Survival3▲ 59×3 topics
- Tumor Microenvironment3▲ 18×4 topics
- Inflammation2▲ 3.2×17 topics
- Endoscopic Resection2▲ 66×2 topics
- Clinical Practice Guidelines2▲ 12×3 topics
- Hepatocellular Carcinoma2▲ 29×3 topics
- Neoadjuvant Therapy2▲ 25×3 topics
- Immunotherapy2▲ 7.9×5 topics
- Breast Cancer2▲ 23×3 topics
- Obesity2▲ 7.1×6 topics
- Gene Expression2▲ 8.0×4 topics
- Cell Death2▲ 20×5 topics
- Precision Medicine2▲ 10×4 topics
- Insulin Resistance2▲ 9.4×4 topics
- Molecular Characterization2▲ 24×2 topics
- Ferroptosis2▲ 53×1 topic
- Hepatic Steatosis2▲ 26×2 topics
- Lipid Peroxidation2▲ 39×1 topic
- Gastric Cancer1▲ 34×1 topic
- Lymph Node Dissection1▲ 65×1 topic
- Medical Imaging1▲ 7.4×2 topics
- Radiotherapy1▲ 10×2 topics
- Biomarkers1▲ 5.2×6 topics
- Body Mass Index1▲ 77×1 topic
- Pregnancy1▲ 18×1 topic
- Prognosis1▲ 9.8×2 topics
- NAFLD1▲ 26×1 topic
- NASH1▲ 26×1 topic
- Quantitative Analysis1▲ 14×1 topic
- Radiomics1▲ 25×1 topic
- Esophageal Carcinoma1▲ 69×1 topic
- Gemcitabine1▲ 38×1 topic
- Human Papillomavirus1▲ 22×1 topic
- Oropharyngeal Cancer1▲ 54×1 topic
- Pancreatic Cancer1▲ 26×2 topics
Which research topics does Qidong Liver Cancer Prevention Research publish most on?
By volume in 2022–2025: Ferroptosis and cancer prognosis, Gastric Cancer Management and Outcomes, Cancer Risks and Factors and Radiomics and Machine Learning in Medical Imaging.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Ferroptosis and cancer prognosis Pulmonary and Respiratory Medicine 2 works
- 2 Gastric Cancer Management and Outcomes Pulmonary and Respiratory Medicine 1 works
- 3 Cancer Risks and Factors Oncology 1 works
- 4 Radiomics and Machine Learning in Medical Imaging Radiology, Nuclear Medicine and Imaging 1 works
- 5 Liver Disease Diagnosis and Treatment Epidemiology 1 works
- 6 Pancreatic and Hepatic Oncology Research Oncology 1 works
- 7 Head and Neck Cancer Studies Otorhinolaryngology 1 works
- 8 Esophageal Cancer Research and Treatment Surgery 1 works
- 9 Hepatocellular Carcinoma Treatment and Prognosis Hepatology 1 works
- 10 Economic and Financial Impacts of Cancer Economics and Econometrics 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Qidong Liver Cancer Prevention Research's research output changed?
Output in 2018–2022 was 0% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.